This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Covidien Announces Highlights From Investor Meeting

Covidien (NYSE: COV), a leading global provider of healthcare products, today outlined the key strategic initiatives, growth opportunities and innovations that are expected to drive the Company’s growth in 2014 and beyond at a meeting held here for the investment community.

Chairman, President and CEO José (Joe) E. Almeida spoke about Covidien’s plans to address the changing healthcare landscape and the Company’s evolving strategies, including broaden innovation focus, portfolio and investment opportunities, emerging markets and operational leverage.

“Despite the challenging external environment, we are delivering a very solid performance in 2013,” Almeida said. “Our focus on growth, leverage and capital allocation will be the drivers of our future performance. We will make further investments to expand our capabilities, particularly in emerging markets, and to capitalize on the market opportunities across our business.

“We are evolving our commercial model, offering value-added services, and launching a steady stream of new products in all product lines. Our strategic investment opportunities, combined with additional portfolio management activities, will accelerate our growth,” he added. “We will use our strong cash flow to fund business expansion, while remaining committed to return at least 50% of our free cash flow to shareholders through dividends and share repurchases.”

Chief Financial Officer Charles Dockendorff provided an outlook for fiscal 2014. The Company estimates that net sales in the 2014 fiscal year will increase 2% to 5% versus 2013 net sales. Net sales are expected to increase 2% to 5% versus 2013 in the Medical Devices segment and be about even with 2013 net sales in Medical Supplies. All sales growth rates assume current foreign exchange rates.

Excluding the impact of one-time items, the operating margin is expected to be in the 21.5% to 22.5% range, and Covidien anticipates the effective tax rate will be in the 16.0% to 17.0% range for fiscal 2014. In addition, the Company is targeting a dividend payout ratio in excess of 35% over time and is committed to achieving a payout ratio of at least 30% within the next 12 months.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,131.86 +47.37 0.28%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,838.6430 +8.1730 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs